1.	Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome Phase: Phase I Type: Treatment Status: Active Age: 50 and over Sponsor: NCI, Other Protocol IDs: 2468.00, NCI-2011-00150, P01CA044991, NCT01300572
2.	90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma Phase: Phase I Type: Treatment Status: Active Age: 18 to 65 Sponsor: NCI, Other Protocol IDs: 2450.00, NCI-2010-02041, R21CA155911, NCT01503242
3.	Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2361.00, NCI-2012-01505, P01CA044991, NCT01678443